SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-20-002728
Filing Date
2020-03-02
Accepted
2020-03-02 16:47:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 56041
2 GRAPHIC g846749g0229001035507.jpg GRAPHIC 2348
3 GRAPHIC g846749g0229001035834.jpg GRAPHIC 1765
  Complete submission text file 0000950123-20-002728.txt   62972
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)